Antibody-drug conjugates (ADCs) are designed to ship exact blows to most cancers cells, very like a well-aimed assault. Nonetheless, the true energy of those therapies lies not solely of their direct, focused affect, but in addition within the broader 'blast radius' and 'bystander killing' impact they generate throughout the tumor microenvironment. To completely perceive and handle this impact, we should […]